The complexity of medication regimens and test ordering for patients with diabetes from 1995 to 2003

References

• UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352: 837–53
   Google Scholar
• UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J 1998;317: 703–13
   Google Scholar
• Pyorala K, Pedersen TR, Kjekshus J, et al. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 1997;20: 614–20
   PubMed Web of Science ®Google Scholar
• Goldberg RB, Mellies MJ, Sacks FM, et al. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the Cholesterol and Recurrent Events Trial. Circulation 1998;98:2513–9
   PubMed Web of Science ®Google Scholar
• Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. New Eng J Med 2003;348:383–93
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2002;25: S33–S49
   Google Scholar
• American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2003;26: S33–S50
   PubMedGoogle Scholar
• American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2004;27:S15–S35
   PubMedGoogle Scholar
• The American Association of Clinical Endocrinologists. Medical guidelines for the management of diabetes mellitus: the AACE system of intensive diabetes self-management – 2002 update. Endocrine Practice 2002;9:41–82
   Google Scholar
• Vijan S, Hayward RA. Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care. Ann Intern Med 2003;138:593–602
   PubMed Web of Science ®Google Scholar
• Vijan S, Hayward RA. Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians. Ann Intern Med 2004;140:650–8
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 1997;20:S5–S13
   Web of Science ®Google Scholar
• Joint National Committee on Prevention, Detection, Evaluation,, and Treatment of High Blood Pressure, and the National High Blood Pressure Education Program Coordinating Committee. The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413–46
   Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. J Am Med Assoc 2003;289:2560–72
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 1999;22: S32–S41
   Web of Science ®Google Scholar
• Clark CM, Fradkin JE, Hiss RG, et al. The national diabetes education program, changing the way diabetes is treated: comprehensive diabetes care. Diabetes Care 2001;24: 617–8
   PubMed Web of Science ®Google Scholar
• Fleming BB, Greenfield S, Engelgau MM, et al. The diabetes quality improvement project. Diabetes Care 2001;24: 1815–20
   PubMed Web of Science ®Google Scholar
• Brown AF, Mangione CM, Saliba D, Sarkisian CA; California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc 2003;51\(Suppl 5):S265–S280
   Google Scholar
• Vijan S, Hayward RA, Ronis DL, Hofer TP. The burden of diabetes therapy: implications for the design of effective patient-centered treatment regimens. J Gen Intern Med 2005;20: 479–82
   Google Scholar
• Kerr EA, Smith DM, Hogan MM, et al. Building a better quality measure: are some patients with ‘poor quality’ actually getting good care? Medical Care 2003;41:1173–82
   PubMed Web of Science ®Google Scholar
• Saydah SH, Fradkin JE, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. J Am Med Assoc 2004;291:335–42
   Google Scholar
• George PB, Tobin KJ, Corpus RA, et al. Treatment of cardiac risk factors in diabetic patients: how well do we follow the guidelines? Am Heart J 2001;142:857–63
   PubMed Web of Science ®Google Scholar
• Saaddine JB, Engelgau MM, Beckles GL, et al. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med 2002;136:565–74
   PubMed Web of Science ®Google Scholar
• Smith NL, Savage PJ, Heckbert SR, et al. Glucose, blood pressure, and lipid control in older people with and without diabetes mellitus: the cardiovascular health study. J Am Geriatr Soc 2002;50:416–32
   PubMed Web of Science ®Google Scholar
• Beckles GL, Engelgau MM, Narayan KMV, et al. Population-based assessment of the level of care among adults with diabetes in the U.S. Diabetes Care 1998;21:1432–8
   PubMed Web of Science ®Google Scholar
• Jencks SF, Cuerdon T, Burwen DR, et al. Quality of medical care delivered to Medicare beneficiaries. J Am Med Assoc 2000;284:1670–6
   PubMed Web of Science ®Google Scholar
• Arday DR, Fleming BB, Keller DK, et al. Variation in diabetes care among states. Diabetes Care 2002;25:2230–7
   PubMed Web of Science ®Google Scholar
• Kerr EA, Gerzoff RB, Krein SL, et al. Diabetes care quality in the Veterans Affairs Health Care System and commercial managed care: the TRIAD study. Ann Intern Med 2004;141:272–81
   PubMed Web of Science ®Google Scholar
• Grant RW, Pirraglia PA, Meigs JB, et al. Trends in complexity of diabetes care in the United States from 1991 to 2000. Arch Intern Med 2004;164:1134–9
   PubMed Web of Science ®Google Scholar
• Nau DP, Garber MC, Herman WH. The intensification of drug therapy for diabetes and its complications: evidence from 2 HMOs. Am J Managed Care 2004;10: 118–23
   Google Scholar
• Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med 2001;135:825–34
   PubMed Web of Science ®Google Scholar
• Hebert PL, Geis LS, Tierney EF, et al. Identifying persons with diabetes using Medicare claims data. Am J Med Qual 1999;14:270–7
   PubMedGoogle Scholar
• Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults [Adult Treatment Panel III]. J Am Med Assoc 2001;285:2486–97
   PubMed Web of Science ®Google Scholar